Cilostazol labels and packages: Difference between revisions

Revision as of 21:21, 28 February 2014

Cilostazol
PLETAL^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Studies
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

PRINCIPAL DISPLAY PANEL - 50mg Bottle Label NDC 59148-003-16

Tablets PLETAL® (cilostazol)

50mg

OTSUKA AMERICA PHARMACEUTICAL, INC.

60 TABLETS

PRINCIPAL DISPLAY PANEL - 100mg Bottle Label NDC 59148-002-16

Tablets PLETAL® (cilostazol)

100mg

OTSUKA AMERICA PHARMACEUTICAL, INC. 60 TABLETS

Adapted from the FDA Package Insert.

@@ Line 4: / Line 4: @@
 ==Labels and Packages==
+'''PRINCIPAL DISPLAY PANEL - 50mg Bottle Label'''
+NDC 59148-003-16
+Tablets
+'''PLETAL®'''
+(cilostazol)
+'''50mg
+OTSUKA AMERICA
+PHARMACEUTICAL, INC.
+TABLETS'''
 {|
 |[[File:Pletal50mg.JPG|600px|thumb]]
 |}
+'''PRINCIPAL DISPLAY PANEL - 100mg Bottle Label'''
+NDC 59148-002-16
+Tablets
+'''PLETAL®'''
+(cilostazol)
+mg
+'''OTSUKA AMERICA
+PHARMACEUTICAL, INC.'''
+TABLETS
 {|
 |[[File:Pletal100mg.JPG|600px|thumb]]
 |}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PLETAL (CILOSTAZOL) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d75b58-bafb-4440-b8d7-4f4079c08b0b | publisher =  | date =  | accessdate =  }}</ref>
 ==References==